Paras Healthcare shares rose 5.4% to a record ₹777 after an early dip, following a market debut at a 3.9% premium to its ₹693 IPO price. Choice Institutional Equities initiated coverage with a Buy rating and ₹900 target, citing growth in specialised care and operational improvements.
Paras Healthcare shares rose 5.4% to a record ₹777 after an early dip, following a market debut at a 3.9% premium to its ₹693 IPO price. Choice Institutional Equities initiated coverage with a Buy rating and ₹900 target, citing growth in specialised care and operational improvements.
<iframe src="https://hindustansphere.com/embed/cluster/ce3b9acf205edd25ac01af6b19fc79ce9d8ac993" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Paras Healthcare shares: After IPO listing gains, check what's happening with stock - Buy, sell or hold?Experts weigh in"></iframe>
